U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.429G>T (p.Lys143Asn) AND Monogenic diabetes

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Mar 22, 2024
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003993706.1

Allele description [Variation Report for NM_000162.5(GCK):c.429G>T (p.Lys143Asn)]

NM_000162.5(GCK):c.429G>T (p.Lys143Asn)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.429G>T (p.Lys143Asn)
Other names:
NM_033508.3:c.426G>T
HGVS:
  • NC_000007.14:g.44151010C>A
  • NG_008847.2:g.52161G>T
  • NM_000162.5:c.429G>TMANE SELECT
  • NM_001354800.1:c.429G>T
  • NM_033507.3:c.432G>T
  • NM_033508.3:c.426G>T
  • NP_000153.1:p.Lys143Asn
  • NP_001341729.1:p.Lys143Asn
  • NP_277042.1:p.Lys144Asn
  • NP_277043.1:p.Lys142Asn
  • LRG_1074t1:c.429G>T
  • LRG_1074t2:c.432G>T
  • LRG_1074:g.52161G>T
  • LRG_1074p1:p.Lys143Asn
  • LRG_1074p2:p.Lys144Asn
  • NC_000007.13:g.44190609C>A
Protein change:
K142N
Molecular consequence:
  • NM_000162.5:c.429G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354800.1:c.429G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033507.3:c.432G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033508.3:c.426G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Monogenic diabetes
Identifiers:
MONDO: MONDO:0015967; MedGen: C3888631

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV004812216ClinGen Monogenic Diabetes Variant Curation Expert Panel
reviewed by expert panel

(ClinGen Monogenic Diabetes ACMG Specifications GCK V1.3.0)		Uncertain significance
(Mar 22, 2024) 		germlinecuration

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Details of each submission

From ClinGen Monogenic Diabetes Variant Curation Expert Panel, SCV004812216.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The c.429G>T variant in the glucokinase gene, GCK, causes an amino acid change of lysine to asparagine at codon 143 (p.(Lys143Asn)) of NM_000162.5. GCK is defined by the ClinGen MDEP as a gene that has a low rate of benign missense variation and has pathogenic missense variants as a common mechanism of disease (PP2). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant was identified in an individual with normal fasting glucose (BS2; PMID: 23799006, internal lab contributors). In summary, c.449T>C meets the criteria to be classified as Uncertain significance for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.3.0 approved 8/11/2023): PM2_Supporting, PP2, BS2.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 20, 2024